Office of Science-Industry Partnerships

Meet Us

Our Vision

By developing collaborative relationships with industry, we will translate the work of our research investigators and clinicians into innovative products, devices and medical technology that will improve the lives of children and their families.

Partnering Opportunities

Latest Partnerships

We’re partnering with companies to turn discoveries into advances that transform pediatric health and well-being. Our latest partnerships include:

 

  • Developing cell therapies for acute myeloid leukemia with bluebird bio
  • Partnering with Moderna to investigate mRNA therapies for hemophilia A
  • Collaborating with Aptahem on aptamer-based treatments for sepsis
  • Investigating a GBS vaccine for pregnant women, with Minervax
  • Working with Nine to prevent stillbirth
  • Studying innovative weight-loss agents with OXT Therapeutics
  • Investigating the role of cadherin in disease
  • Collaborating with UCB to identify mechanisms behind intractable epilepsy
  • Working with Casebia Therapeutics to develop cell therapies for autoimmune disease
  • Investigating mRNA therapies developed by Moderna Therapeutics for rare genetic disorders
  • Creating a cost-effective, easy-to-use test for drug-resistant HIV, with help from InBios International
  • Collaborating with Immunexpress to pursue a screening test for sepsis

 

Learn more about our latest partnerships.